Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Global Cannabis Applications

DB:2FA
Snowflake Description

Worrying balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
2FA
DB
CA$2M
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

Global Cannabis Applications Corp. designs, develops, markets, and acquires data technologies for the medical cannabis industry. The last earnings update was 37 days ago. More info.


Add to Portfolio Compare Print
  • Global Cannabis Applications has significant price volatility in the past 3 months.
2FA Share Price and Events
7 Day Returns
-1%
DB:2FA
16.8%
DE Healthcare Services
2.1%
DE Market
1 Year Returns
-83.3%
DB:2FA
15.8%
DE Healthcare Services
-16.6%
DE Market
2FA Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Global Cannabis Applications (2FA) -1% -9.1% -63% -83.3% -79.6% -94.6%
DE Healthcare Services 16.8% 4.4% -1.9% 15.8% 50.3% 117%
DE Market 2.1% -12.6% -22.9% -16.6% -21.9% -27.8%
1 Year Return vs Industry and Market
  • 2FA underperformed the Healthcare Services industry which returned 15.8% over the past year.
  • 2FA underperformed the Market in Germany which returned -16.6% over the past year.
Price Volatility
2FA
Industry
5yr Volatility vs Market

Value

 Is Global Cannabis Applications undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.

In this section, we usually try to help investors determine whether Global Cannabis Applications is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Global Cannabis Applications has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.

Show me the analysis anyway

INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Global Cannabis Applications. This is due to cash flow or dividend data being unavailable. The share price is €0.01.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Global Cannabis Applications's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Global Cannabis Applications's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:2FA PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in CAD CA$-0.05
CNSX:APP Share Price ** CNSX (2020-04-07) in CAD CA$0.02
Germany Healthcare Services Industry PE Ratio Median Figure of 6 Publicly-Listed Healthcare Services Companies 11.51x
Germany Market PE Ratio Median Figure of 402 Publicly-Listed Companies 16.83x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Global Cannabis Applications.

DB:2FA PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:APP Share Price ÷ EPS (both in CAD)

= 0.02 ÷ -0.05

-0.38x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Global Cannabis Applications is loss making, we can't compare its value to the DE Healthcare Services industry average.
  • Global Cannabis Applications is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does Global Cannabis Applications's expected growth come at a high price?
Raw Data
DB:2FA PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -0.38x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Europe Healthcare Services Industry PEG Ratio Median Figure of 14 Publicly-Listed Healthcare Services Companies 2.68x
Germany Market PEG Ratio Median Figure of 256 Publicly-Listed Companies 1.22x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Global Cannabis Applications, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Global Cannabis Applications's assets?
Raw Data
DB:2FA PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in CAD CA$-0.01
CNSX:APP Share Price * CNSX (2020-04-07) in CAD CA$0.02
Germany Healthcare Services Industry PB Ratio Median Figure of 7 Publicly-Listed Healthcare Services Companies 2.82x
Germany Market PB Ratio Median Figure of 573 Publicly-Listed Companies 1.45x
DB:2FA PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:APP Share Price ÷ Book Value per Share (both in CAD)

= 0.02 ÷ -0.01

-3.24x

* Primary Listing of Global Cannabis Applications.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Global Cannabis Applications has negative assets, we can't compare the value of its assets to the DE Healthcare Services industry average.

Next steps:

  1. Take a look at our analysis of 2FA’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Global Cannabis Applications's regulatory filings and announcements.
  3. Show me more potentially undervalued companies in the Healthcare Services industry
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Value checks
We assess Global Cannabis Applications's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check)
  5. Global Cannabis Applications has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Global Cannabis Applications expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Global Cannabis Applications has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
26.9%
Expected Healthcare Services industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Global Cannabis Applications expected to grow at an attractive rate?
  • Unable to compare Global Cannabis Applications's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Global Cannabis Applications's earnings growth to the Germany market average as no estimate data is available.
  • Unable to compare Global Cannabis Applications's revenue growth to the Germany market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
DB:2FA Future Growth Rates Data Sources
Data Point Source Value (per year)
Europe Healthcare Services Industry Earnings Growth Rate Market Cap Weighted Average 26.9%
Europe Healthcare Services Industry Revenue Growth Rate Market Cap Weighted Average 8.1%
Germany Market Earnings Growth Rate Market Cap Weighted Average 14%
Germany Market Revenue Growth Rate Market Cap Weighted Average 3.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:2FA Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:2FA Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-12-31 0 -5
2019-09-30 -1 -6
2019-06-30 -3 -8
2019-03-31 -4 -6
2018-12-31 -5 -7
2018-09-30 -5 -7
2018-06-30 -4 -5
2018-03-31 -3 -4
2017-12-31 -2 -2
2017-09-30 -1 -1
2017-06-30 -1 -1
2017-03-31 0 -2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Global Cannabis Applications is high growth as no earnings estimate data is available.
  • Unable to determine if Global Cannabis Applications is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:2FA Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Global Cannabis Applications Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:2FA Past Financials Data
Date (Data in CAD Millions) EPS *
2019-12-31 -0.05
2019-09-30 -0.06
2019-06-30 -0.08
2019-03-31 -0.06
2018-12-31 -0.08
2018-09-30 -0.10
2018-06-30 -0.09
2018-03-31 -0.08
2017-12-31 -0.05
2017-09-30 -0.04
2017-06-30 -0.04
2017-03-31 -0.08

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Global Cannabis Applications will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Take a look at our analysis of 2FA’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. Global Cannabis Applications's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  3. Global Cannabis Applications's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Global Cannabis Applications's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Global Cannabis Applications has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Global Cannabis Applications performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Global Cannabis Applications's growth in the last year to its industry (Healthcare Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Global Cannabis Applications does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Global Cannabis Applications's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Global Cannabis Applications's 1-year growth to the DE Healthcare Services industry average as it is not currently profitable.
Earnings and Revenue History
Global Cannabis Applications's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Global Cannabis Applications Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:2FA Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 -5.30 1.69 0.61
2019-09-30 -6.09 2.04 1.13
2019-06-30 -7.56 3.59 1.13
2019-03-31 -5.52 4.89 0.75
2018-12-31 -6.70 5.99 0.65
2018-09-30 -6.78 6.39 0.19
2018-06-30 -5.47 4.92 0.21
2018-03-31 -3.63 3.12 0.14
2017-12-31 -2.40 1.94 0.14
2017-09-30 -1.48 1.10 0.09
2017-06-30 -1.48 1.11 0.09
2017-03-31 -2.28 1.94 -0.01
2016-12-31 -2.04 1.70 -0.02
2016-09-30 -1.92 1.59 -0.03
2016-06-30 -2.22 1.81 0.05
2016-03-31 -1.58 0.96 0.34
2015-12-31 -1.78 1.18 0.34
2015-09-30 -1.87 1.31 0.34
2015-06-30 -1.63 1.20 0.24
2014-06-30 -0.23 0.23

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Global Cannabis Applications has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.
  • It is difficult to establish if Global Cannabis Applications has efficiently used its assets last year compared to the DE Healthcare Services industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Global Cannabis Applications improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.
X
Past performance checks
We assess Global Cannabis Applications's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Global Cannabis Applications has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Global Cannabis Applications's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Global Cannabis Applications's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Global Cannabis Applications's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Global Cannabis Applications has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Global Cannabis Applications's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Global Cannabis Applications has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Global Cannabis Applications Company Filings, last reported 3 months ago.

DB:2FA Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 -0.71 0.40 0.01
2019-09-30 -0.90 0.39 0.00
2019-06-30 -0.66 0.39 0.01
2019-03-31 3.22 0.38 0.02
2018-12-31 3.34 0.37 0.06
2018-09-30 3.41 0.47 0.19
2018-06-30 3.31 0.47 0.63
2018-03-31 4.79 0.42 4.49
2017-12-31 0.82 0.41 0.65
2017-09-30 0.42 0.40 0.11
2017-06-30 0.46 0.40 0.11
2017-03-31 0.25 0.45 0.07
2016-12-31 0.20 0.44 0.00
2016-09-30 0.11 0.44 0.01
2016-06-30 -0.25 0.46 0.02
2016-03-31 -0.17 0.43 0.04
2015-12-31 0.03 0.36 0.04
2015-09-30 -0.01 0.35 0.07
2015-06-30 -0.13 0.42 0.03
2014-06-30 0.25 0.00 0.24
  • Global Cannabis Applications has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.
  • Irrelevant to check if Global Cannabis Applications's debt level has increased considering it has negative shareholder equity.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Global Cannabis Applications has less than a year of cash runway based on current free cash flow.
  • Global Cannabis Applications has less than a year of cash runway if free cash flow continues to grow at historical rates of 27.9% each year.
X
Financial health checks
We assess Global Cannabis Applications's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Global Cannabis Applications has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Global Cannabis Applications's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Global Cannabis Applications dividends.
If you bought €2,000 of Global Cannabis Applications shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Global Cannabis Applications's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Global Cannabis Applications's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:2FA Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Europe Healthcare Services Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 1.4%
Germany Market Average Dividend Yield Market Cap Weighted Average of 314 Stocks 3.7%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.7%
Germany Top 25% Dividend Yield 75th Percentile 4.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Global Cannabis Applications has not reported any payouts.
  • Unable to verify if Global Cannabis Applications's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Global Cannabis Applications's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Global Cannabis Applications has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Global Cannabis Applications's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Global Cannabis Applications afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Global Cannabis Applications has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Global Cannabis Applications's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Brad Moore
COMPENSATION CA$343,039
TENURE AS CEO 4.2 years
CEO Bio

Mr. Bradley Moore, also known as Brad, has been the Chief Executive Officer and Director at Global Cannabis Applications Corp. (formerly, Fundamental Applications Corp.) since February 03, 2016. Mr. Moore has 20 years of practical business leadership experience with Fortune 500 companies, including nine years with Eastman Kodak (NYSE: KODK), and a strong background in growing internet-based companies. With a proven track record in surpassing objectives, restructuring and developing businesses, Mr. Moore is recognized as the next level of management for Fundamental's suite of applications. Mr. Moore holds an MBA from Royal Roads University.

CEO Compensation
  • Brad's compensation has increased whilst company is loss making.
  • Brad's remuneration is lower than average for companies of similar size in Germany.
Management Team Tenure

Average tenure of the Global Cannabis Applications management team in years:

4.2
Average Tenure
  • The tenure for the Global Cannabis Applications management team is about average.
Management Team

Brad Moore

TITLE
CEO & Director
COMPENSATION
CA$343K
TENURE
4.2 yrs

Alex Helmel

TITLE
CFO, Corporate Secretary & Director
COMPENSATION
CA$102K
AGE
49
TENURE
4.5 yrs

Alon Tzipory

TITLE
Chief Operating Officer
TENURE
1.4 yrs

Hanan Gelbendorf

TITLE
Chief Marketing Officer

Anastasija Plotnikova

TITLE
Chief Operating Officer of GCAC Europe

Nick Miller

TITLE
COMPENSATION
CA$28K
AGE
67
TENURE
4.9 yrs

Tony Guoga

TITLE
Advisor & Member of Initial Coin Offering Advisory Board
TENURE
2.4 yrs
Board of Directors Tenure

Average tenure of the Global Cannabis Applications board of directors in years:

3.9
Average Tenure
  • The tenure for the Global Cannabis Applications board of directors is about average.
Board of Directors

Brad Moore

TITLE
CEO & Director
COMPENSATION
CA$343K
TENURE
4.2 yrs

Alex Helmel

TITLE
CFO, Corporate Secretary & Director
COMPENSATION
CA$102K
AGE
49
TENURE
4.9 yrs

Jeff Hayzlett

TITLE
Independent Director
COMPENSATION
CA$32K
TENURE
3.7 yrs

Scott Walker

TITLE
Member of Advisory Board

Tony Guoga

TITLE
Advisor & Member of Initial Coin Offering Advisory Board
TENURE
2.3 yrs

Samuel, Sam Lee

TITLE
Member of Advisory Board

Jonathan Grunfeld

TITLE
Member of Advisory Board
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
28. Nov 19 Buy Hanan Gelbendorf Individual 22. Nov 19 22. Nov 19 2,000,000 €0.03 €68,202
X
Management checks
We assess Global Cannabis Applications's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Global Cannabis Applications has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Global Cannabis Applications Corp. designs, develops, markets, and acquires data technologies for the medical cannabis industry. It offers Citizen Green platform, an end to end medical cannabis data solution. The company was formerly known as Fundamental Applications Corp. Global Cannabis Applications Corp. was founded in 2014 and is headquartered in Vancouver, Canada.

Details
Name: Global Cannabis Applications Corp.
2FA
Exchange: DB
Founded: 2014
CA$1,499,642
114,712,001
Website: http://cannappscorp.com
Address: Global Cannabis Applications Corp.
1100 Melville Street,
Suite 830,
Vancouver,
British Columbia, V6E 4A6,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX APP Common Shares Canadian National Stock Exchange CA CAD 06. Nov 2014
DB 2FA Common Shares Deutsche Boerse AG DE EUR 06. Nov 2014
Number of employees
Current staff
Staff numbers
0
Global Cannabis Applications employees.
Industry
Health Care Technology
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/08 02:52
End of day share price update: 2020/04/07 00:00
Last earnings filing: 2020/03/02
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.